Free Trial

Intelligent Bio Solutions (INBS) Competitors

Intelligent Bio Solutions logo
$1.30 +0.03 (+2.36%)
(As of 12/20/2024 05:40 PM ET)

INBS vs. CODX, VVOS, DRIO, ALUR, NRXS, MBOT, NEPH, LUCY, LFWD, and IINN

Should you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include Co-Diagnostics (CODX), Vivos Therapeutics (VVOS), DarioHealth (DRIO), Allurion Technologies (ALUR), NeurAxis (NRXS), Microbot Medical (MBOT), Nephros (NEPH), Innovative Eyewear (LUCY), ReWalk Robotics (LFWD), and Inspira Technologies Oxy B.H.N. (IINN). These companies are all part of the "medical equipment" industry.

Intelligent Bio Solutions vs.

Co-Diagnostics (NASDAQ:CODX) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, community ranking, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Intelligent Bio Solutions has lower revenue, but higher earnings than Co-Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Co-Diagnostics$7.32M3.18-$35.33M-$1.38-0.53
Intelligent Bio Solutions$3.19M1.79-$10.16MN/AN/A

Co-Diagnostics received 273 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users.

CompanyUnderperformOutperform
Co-DiagnosticsOutperform Votes
273
62.90%
Underperform Votes
161
37.10%
Intelligent Bio SolutionsN/AN/A

In the previous week, Intelligent Bio Solutions had 3 more articles in the media than Co-Diagnostics. MarketBeat recorded 3 mentions for Intelligent Bio Solutions and 0 mentions for Co-Diagnostics. Intelligent Bio Solutions' average media sentiment score of 0.87 beat Co-Diagnostics' score of 0.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company Overall Sentiment
Co-Diagnostics Neutral
Intelligent Bio Solutions Positive

Co-Diagnostics has a beta of -0.91, meaning that its stock price is 191% less volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.72, meaning that its stock price is 372% more volatile than the S&P 500.

15.0% of Co-Diagnostics shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 6.1% of Co-Diagnostics shares are held by insiders. Comparatively, 0.3% of Intelligent Bio Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Intelligent Bio Solutions has a net margin of -288.35% compared to Co-Diagnostics' net margin of -563.93%. Co-Diagnostics' return on equity of -54.94% beat Intelligent Bio Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Co-Diagnostics-563.93% -54.94% -49.28%
Intelligent Bio Solutions -288.35%-147.50%-81.21%

Co-Diagnostics currently has a consensus price target of $1.50, suggesting a potential upside of 105.48%. Given Co-Diagnostics' stronger consensus rating and higher probable upside, equities analysts plainly believe Co-Diagnostics is more favorable than Intelligent Bio Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Co-Diagnostics
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Intelligent Bio Solutions
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Co-Diagnostics beats Intelligent Bio Solutions on 8 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INBS vs. The Competition

MetricIntelligent Bio SolutionsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$5.70M$4.34B$5.13B$9.07B
Dividend YieldN/A44.57%5.08%4.23%
P/E RatioN/A25.3789.5817.17
Price / Sales1.7945.951,116.12116.95
Price / CashN/A43.4542.8237.86
Price / Book0.557.094.774.78
Net Income-$10.16M$13.64M$120.15M$225.60M
7 Day Performance-12.16%-2.93%-1.92%-1.23%
1 Month Performance-20.73%0.28%11.47%3.36%
1 Year Performance-68.69%40.76%30.52%16.60%

Intelligent Bio Solutions Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INBS
Intelligent Bio Solutions
1.0388 of 5 stars
$1.30
+2.4%
N/A-68.7%$5.70M$3.19M0.0010Positive News
CODX
Co-Diagnostics
3.8295 of 5 stars
$0.79
-4.7%
$1.50
+89.1%
-39.7%$25.32M$7.32M-0.60100
VVOS
Vivos Therapeutics
2.8401 of 5 stars
$4.97
+7.8%
$6.30
+26.8%
-57.7%$24.06M$13.80M-0.81160Positive News
Gap Up
DRIO
DarioHealth
2.2551 of 5 stars
$0.70
-3.8%
$4.00
+468.2%
-51.2%$24.00M$23.05M-0.78200News Coverage
Positive News
ALUR
Allurion Technologies
2.0377 of 5 stars
$0.34
-2.8%
$2.88
+755.7%
-90.2%$21.63M$34.75M-0.67501Gap Up
NRXS
NeurAxis
N/A$2.44
-1.6%
N/A+5.3%$17.03M$2.46M-1.3519Gap Down
High Trading Volume
MBOT
Microbot Medical
1.9092 of 5 stars
$1.00
flat
$7.00
+600.0%
-29.2%$16.93MN/A-1.2520
NEPH
Nephros
1.6901 of 5 stars
$1.55
flat
$5.00
+222.6%
-47.6%$16.34M$13.55M-17.2230Positive News
LUCY
Innovative Eyewear
1.7076 of 5 stars
$6.52
+6.7%
$20.00
+206.7%
-32.6%$15.92M$1.56M-0.669
LFWD
ReWalk Robotics
3.3589 of 5 stars
$1.65
flat
$13.00
+687.9%
N/A$14.53M$25.00M-0.6260Positive News
Gap Up
High Trading Volume
IINN
Inspira Technologies Oxy B.H.N.
0.3107 of 5 stars
$1.13
-3.8%
N/A-21.9%$14.20MN/A0.0020

Related Companies and Tools


This page (NASDAQ:INBS) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners